Share your goals
Tell us about your health history, current medications and weight-management goals through a private online intake.
Wellness & Recovery
Educational information Not available for prescribing
Retatrutide
An investigational triple agonist being studied for obesity and weight-related conditions. This page explains current research and directs visitors towards approved treatment options.
Explore Approved Options- Private online intake
- Licensed provider review
- Approved treatments only
Educational information
Illustrative care image presented for educational use.
- Research stage
- Clinical development
- Mechanism
- Triple agonist
- Studied route
- Weekly injection
- Research focus
- Weight management
Treatment overview
What It Is & How It Works
Retatrutide is a triple agonist designed to activate GIP, GLP-1 and glucagon receptors. Researchers are studying whether this combined pathway can support weight reduction and related metabolic outcomes.
Explore available care
Approved options with clear next steps
Review approved options
A licensed provider evaluates whether an approved and legally available treatment may be appropriate for you.
Receive a personalised plan
Eligible patients receive provider-directed treatment instructions, support and follow-up guidance.
Available care
What Can You Discuss Today?
A licensed provider can assess whether an approved weight-management option may be appropriate based on your health history, current medications and goals.
Important safety information
Research Safety Information
Do not purchase products claiming to be Retatrutide online or labelled “for research use only”. In the United States, Retatrutide is not currently eligible for compounding under federal law.
Clinical studies have reported gastrointestinal side effects and dose-related increases in heart rate. Its complete safety profile and prescribing information have not been established.
Frequently asked questions
What to know now
What is Retatrutide’s current status?
Retatrutide remains investigational and is not available for prescribing. It should only be used within an authorised clinical trial.
How does Retatrutide work?
Retatrutide is a triple agonist designed to activate GIP, GLP-1 and glucagon receptors. This combined pathway is being studied for obesity and related metabolic conditions.
Can I obtain compounded or “research” Retatrutide?
In the United States, Retatrutide is not currently eligible for compounding under federal law. Consumers should not purchase products sold online as Retatrutide or labelled for research use.
Discuss approved weight-management options through a private online consultation.
Explore treatments available today
Start with a private online intake. A licensed provider will review your information and guide you from there.